Bob Rambo

Bob Rambo has over 30 years of experience in the biopharmaceutical industry. Bob began their career in 1987 as a Research Assistant at Penn State University. In 1989, they joined Merck as a Professional Sales Representative and worked their way up to become the Global Brand Leader of the MK-7110 COVID-19 Therapeutics, Global Brand Leader of the Hepatitis/Hepatology and NASH Franchise, Global Marketing Director of the Hepatitis C Franchise, and Global Team Leader of Academic Professional Engagement. In 2021, they joined RJR Consulting Group, LLC as a Principal and is currently the Executive Vice President of Marketing and Medical Affairs at NewAmsterdam Pharma.

Bob Rambo received their MBA in Marketing from the Fox School of Business at Temple University between 1990 and 1993. Bob also earned their BS in Microbiology from Penn State University between 1983 and 1987.